Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,227 full-time employees. The company went IPO on 2014-10-21. The firm offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The firm conducts its business in one segment, which provides its medical device products to healthcare providers and patients with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. Its surgical pain and recovery products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. Its interventional pain solutions include COOLIEF chronic pain products, OrthogenRx knee osteoarthritis hyaluronic acid (HA) pain relief injection products (GenVisc and TriVisc) and Trident radiofrequency ablation (RFA) products.
Follow-Up Questions
Who is the CEO of Avanos Medical Inc?
Mr. David Pacitti is the Chief Executive Officer of Avanos Medical Inc, joining the firm since 2025.
What is the price performance of AVNS stock?
The current price of AVNS is $11.41, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Avanos Medical Inc?
Avanos Medical Inc belongs to Health Care industry and the sector is Health Care
What is Avanos Medical Inc market cap?
Avanos Medical Inc's current market cap is $529.4M
Is Avanos Medical Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Avanos Medical Inc, including 0 strong buy, 0 buy, 3 hold, 1 sell, and 0 strong sell
